GlassScriptPhysician profile
Benjamin Carl Smith
NPI 1619266772
$8,708.94
in general payments reported to CMS, 2019-2025
24 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,311 · 2020: $894 · 2021: $1,835 · 2022: $1,250 · 2023: $1,850 · 2024: $1,290 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,126 · Travel and Lodging: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,126.18 |
| Travel and Lodging | $292.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,078.32 | 2021-2024 | Axonics, Bulkamid |
| Medtronic USA, INC. | $1,568.37 | 2019-2020 | |
| Medtronic, INC. | $1,246.77 | 2021-2025 | Interstim, Ligasure |
| Caldera Medical, INC | $851.02 | 2021-2024 | Desara |
| Coloplast Corp | $583.66 | 2019-2025 | Speedicath, Altis |
| Astellas Pharma US INC | $474.70 | 2019-2024 | Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $170.05 | 2023-2025 | Gemtesa |
| Urovant Sciences INC | $113.31 | 2021-2022 | |
| Boston Scientific Corporation | $111.92 | 2019-2025 | Axonics, General - Female Sui |
| Coopersurgical, INC. | $111.23 | 2020 | |
| Glaxosmithkline, LLC. | $65.72 | 2019-2021 | |
| Inspire Medical Systems, INC. | $56.55 | 2023 | Inspire |
| Abbvie INC. | $40.63 | 2021-2022 | |
| Pfizer INC. | $34.58 | 2022-2024 | |
| Amag Pharmaceuticals, INC. | $33.40 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monaghan Medical Corporation | $24.94 | 2024 | Aerochamber |
| Vertex Pharmaceuticals Incorporated | $23.25 | 2025 | |
| Myovant Sciences INC. | $20.55 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.45 | 2019 | |
| Allergan, INC. | $19.05 | 2021 | |
| Northgate Technologies, INC. | $18.15 | 2024 | Stimsite |
| Exeltis, USA INC. | $15.55 | 2023 | Slynd |
| Mimedx Group, INC. | $14.78 | 2024 | |
| Valencia Technologies Corporation | $12.99 | 2023 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.